Venture Capital Investors

Frazier Healthcare Partners

Frazier Healthcare Partners makes VC investments in companies focused on high-impact, technology-driven solutions.

Venture Investor Overview

Venture Investor
Frazier Healthcare Partners
Status
InActive
Investor Type
Venture Capital
Activity Level
219 transactions
Funds Raised
At least $3.7 billion
Industry Focus
Biopharmaceutical
Healthcare Services

Contact Information

Contact
Alan Frazier
Title
Managing Partner
Mailing Address
70 Willow Rd. 200
Menlo Park, CA 94025
USA
Phone
(206) 621-7200
Website
www.frazierhealthcare.com
Email Address
Not Recorded

Background Information

Overview
In terms of the stage of our investment focus, we invest in both venture capital and growth equity opportunities. Within our venture program, we invest in biopharma and medical device companies across the entire spectrum of their development from early to late stage and PIPEs. Within our growth equity program, we invest in healthcare companies that have already achieved positive cash flow and that have the potential for high growth.
Profile
Frazier Healthcare Partners LinkedIn Company Profile
Social Media
Frazier Healthcare Partners Company Twitter Account
Company News
Frazier Healthcare Partners News
Facebook
Frazier Healthcare Partners on Facebook
YouTube
Frazier Healthcare Partners on YouTube
Last Transaction
12/14/2022

Transaction History

Our records indicate that Frazier Healthcare Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Alpha-9 Theranostics
12/14/2022
$75,000,000
MBX Biosciences
11/14/2022
$115,000,000
Sudo Biosciences
9/28/2022
$37,000,000
Aspen Neuroscience
5/9/2022
$147,500,000
Metagenomi
2/2/2022
$175,000,000
HilleVax
9/9/2021
$135,000,000
Sonoma Biotherapeutics
8/5/2021
$265,000,000
Amunix Pharmaceuticals
3/5/2021
$117,000,000
Seraxis
2/10/2021
$40,000,000
Imago BioSciences
11/20/2020
$80,000,000
Inipharm
11/12/2020
$35,000,000
MBX Biosciences
7/29/2020
$34,600,000
Dascena
5/1/2020
$50,000,000
Aspen Neuroscience
4/2/2020
$70,000,000
SutroVax
3/27/2020
$110,000,000
Amunix Pharmaceuticals
3/5/2020
$73,000,000
Tarsus Pharmaceuticals
1/9/2020
$60,000,000
Phathom Pharmaceuticals
5/16/2019
$140,000,000
Scout Bio
4/11/2019
$20,000,000
Imago BioSciences
3/22/2019
$40,000,000
Passage Bio
2/19/2019
$115,500,000
Recida Therapeutics
2/7/2019
$8,500,000
Sojournix
1/4/2019
$44,000,000
Mirum Pharmaceuticals
11/8/2018
$120,000,000
SutroVax
6/8/2018
$85,000,000
Aptinyx
12/19/2017
$70,000,000
Mavupharma
11/30/2017
$20,000,000
Outpost Medicine
11/16/2017
$20,000,000
Gritstone Oncology
9/8/2017
$92,700,000
Entasis Therapeutics
9/6/2017
$31,900,000
Iterum Therapeutics
5/20/2017
$65,000,000
Cirius Therapeutics
4/11/2017
$40,000,000
SutroVax
3/22/2017
$64,000,000
Alpine Immune Sciences
6/14/2016
$48,000,000
Aptinyx
5/11/2016
$65,000,000
Entasis Therapeutics
4/5/2016
$50,000,000
Alcresta Therapeutics
3/31/2016
$5,999,000
Gritstone Oncology
3/31/2016
$35,735,000
PowerVision
3/31/2016
$10,000,000
Zavante Therapeutics
3/30/2016
$45,000,000
Iterum Therapeutics
3/25/2016
$40,000,000
Outpost Medicine
3/16/2016
$41,000,000
Millendo Therapeutics
1/4/2016
$62,000,000
Allena Pharmaceuticals
12/9/2015
$53,000,000
Gritstone Oncology
10/21/2015
$102,000,000
Imago BioSciences
9/30/2015
$8,800,000
Elements Behavioral Health
9/30/2015
$4,999,000
AnaptysBio
7/16/2015
$40,000,000
Semnur Pharmaceuticals
3/31/2015
$10,000,000
Elements Behavioral Health
3/31/2015
$6,500,000
Collegium Pharmaceutical
3/11/2015
$50,000,000
Merganser Biotech
2/19/2015
$28,000,000
Laguna Pharmaceuticals
2/17/2015
$30,000,000
Allena Pharmaceuticals
11/14/2014
$25,000,000
Imago BioSciences
11/4/2014
$26,500,000
Cidara Therapeutics
6/30/2014
$32,000,000
ProNAi Therapeutics
4/22/2014
$59,500,000
Allena Pharmaceuticals
3/31/2014
$333,000
PowerVision
1/28/2014
$20,000,000
Acerta Pharma
12/31/2013
$13,000,100
Alcresta Therapeutics
7/22/2013
$10,000,000
Elements Behavioral Health
6/30/2013
$99,900
Silvergate Pharmaceuticals
6/17/2013
$23,554,167
Rempex Pharmaceuticals
3/31/2013
$20,000,000
Millendo Therapeutics
3/31/2013
$5,017,000
Glaukos
2/8/2013
$30,000,000
Abode Healthcare
12/31/2012
$10,000,000
Precision Dermatology
12/31/2012
$25,599,900
Silvergate Pharmaceuticals
9/30/2012
$7,000,000
Alcresta Therapeutics
9/30/2012
$5,000,000
Elements Behavioral Health
9/30/2012
$10,000,000
Millendo Therapeutics
8/6/2012
$16,000,000
Allena Pharmaceuticals
6/30/2012
$7,500,000
Abode Healthcare
6/30/2012
$13,100,000
Alcresta Therapeutics
4/18/2012
$10,000,000
Kalidex Pharmaceuticals
3/31/2012
$6,499,900
Moximed
3/31/2012
$1,770,000
VentiRx Pharmaceuticals
3/31/2012
$6,250,100
Collegium Pharmaceutical
2/22/2012
$22,500,000
Moximed
12/31/2011
$2,568,000
PowerVision
12/31/2011
$12,500,100
Elements Behavioral Health
12/31/2011
$21,264,000
Allena Pharmaceuticals
11/17/2011
$15,000,000
Rempex Pharmaceuticals
11/9/2011
$67,500,000
Incline Therapeutics
9/30/2011
$21,500,000
Silvergate Pharmaceuticals
6/30/2011
$3,015,000
Moximed
6/30/2011
$43,269,900
Oceana Therapeutics
6/30/2011
$23,935,000
Finsphere
3/31/2011
$1,749,900
PowerVision
12/31/2010
$30,000
Kalidex Pharmaceuticals
12/31/2010
$251,000
Precision Dermatology
12/31/2010
$19,000,000
Achaogen
12/31/2010
$20,952,300
Tobira Therapeutics
12/31/2010
$1,500,000
Calistoga Pharmaceuticals
12/31/2010
$5,719,000
Cardiac Dimensions
12/31/2010
$6,446,900
Calibra Medical
9/30/2010
$2,000,000
Tobira Therapeutics
9/30/2010
$31,000,000
PowerVision
9/30/2010
$20,500,000
BARRX Medical
7/14/2010
$15,000,000
Centri Technology
6/30/2010
$325,000
Calistoga Pharmaceuticals
6/30/2010
$40,000,000
Incline Therapeutics
6/22/2010
$43,000,000
CoolSculpting
6/2/2010
$25,000,000
Achaogen
4/7/2010
$56,000,000
Nuon Therapeutics
3/17/2010
$6,050,000
Alnara Pharmaceuticals
1/28/2010
$35,000,000
VentiRx Pharmaceuticals
1/12/2010
$25,000,000
EBR Systems
12/31/2009
$15,000,000
Aveso Displays
12/31/2009
$1,300,000
Clovis Oncology
12/31/2009
$65,635,000
Trident USA Health Services
12/31/2009
$5,950,000
DS-IQ
12/31/2009
Unknown
Calibra Medical
11/24/2009
$1,400,000
Threshold Pharmaceuticals
10/7/2009
$35,000,000
Calypso Medical Technologies
9/17/2009
$50,000,000
BaroSense
8/21/2009
$27,000,000
Clovis Oncology
6/30/2009
$146,300,000
Calistoga Pharmaceuticals
5/5/2009
$30,000,000
Primaeva Medical
2/21/2009
$6,000,000
Calixa Therapeutics
12/31/2008
$15,125,000
Arete Therapeutics
11/19/2008
$16,700,000
Alnara Pharmaceuticals
10/30/2008
$20,000,000
Tobira Therapeutics
9/30/2008
$30,000,000
Primaeva Medical
9/30/2008
$1,500,000
PatientKeeper
8/10/2008
$7,500,000
Xoft
8/4/2008
$25,000,000
CVRx
7/30/2008
$84,000,000
EBR Systems
7/29/2008
$35,000,000
CoolSculpting
6/30/2008
$25,000,000
Seattle Medical Technologies
5/2/2008
$21,000,000
Nuon Therapeutics
4/28/2008
$27,000,000
StroMedix
4/21/2008
$25,000,000
MacuSight
3/31/2008
$700,200
Control4
3/31/2008
$20,000,000
Ascension Orthopedics
1/21/2008
$21,000,000
Calistoga Pharmaceuticals
1/3/2008
$5,200,000
ZONARE Medical Systems
12/31/2007
$15,000,000
Calistoga Pharmaceuticals
12/31/2007
$15,735,000
Pivot Medical
12/31/2007
$8,000,000
BaroSense
12/31/2007
$4,231,000
Cardiac Dimensions
12/18/2007
$35,500,000
AnaptysBio
11/8/2007
$33,900,000
CoolSculpting
10/30/2007
$20,300,000
Metastatix
10/9/2007
$35,000,000
Medio Systems
9/30/2007
$5,010,000
Bravo Health
9/30/2007
$71,957,100
FlowCardia
8/31/2007
$30,000,000
Tobira Therapeutics
8/1/2007
$31,000,000
Cardiac Dimensions
6/30/2007
$4,004,000
Juniper Medical
6/30/2007
$38,100
Arete Therapeutics
5/23/2007
$13,300,000
QuatRx Pharmaceuticals
5/22/2007
$44,000,000
Marcadia Biotech
5/15/2007
$15,000,000
Synovis Orthopedic and Woundcare
5/10/2007
$20,000,000
CVRx
5/9/2007
$65,000,000
Portola Pharmaceuticals
5/7/2007
$70,000,000
Xoft
4/5/2007
$33,200,000
Pivot Trader
3/31/2007
$2,000,000
StroMedix
3/21/2007
$1,000,000
VentiRx Pharmaceuticals
3/6/2007
$28,900,000
Calistoga Pharmaceuticals
3/6/2007
$21,000,000
Chimerix
2/23/2007
$23,100,000
InnerPulse
1/30/2007
$50,000,000
Primaeva Medical
12/13/2006
$7,000,000
Bariatric Partners
11/27/2006
$12,000,000
Intradigm
11/21/2006
$16,000,000
Seattle Medical Technologies
9/30/2006
$8,349,900
MacuSight
9/30/2006
$8,000,000
Juniper Medical
9/30/2006
$10,000,000
Aveso Displays
9/30/2006
$6,250,000
Amicus Therapeutics
9/14/2006
$60,000,000
BARRX Medical
7/20/2006
$27,800,000
Clearsight Systems
6/30/2006
$5,550,000
PatientKeeper
6/14/2006
$8,000,000
CVRx
5/11/2006
$30,100,000
Cadence Pharmaceuticals
3/31/2006
$53,800,000
Juniper Medical
3/31/2006
$3,600,100
Primaeva Medical
3/31/2006
$1,000,000
Aprimo
3/31/2006
$534,000
Panomics
3/31/2006
$12,235,200
SNAPin Software
3/31/2006
$13,000,000
Avera Pharmaceuticals
3/31/2006
$17,999,700
Portola Pharmaceuticals
11/8/2005
$46,000,000
Apneon
9/30/2005
$12,000,000
Amicus Therapeutics
9/8/2005
$55,000,000
Cerexa
8/23/2005
$50,000,000
Control4
7/15/2005
$15,000,000
SNAPin Software
6/30/2005
$3,000,000
IP Fabrics
6/30/2005
$906,000
Fovi Optics
6/30/2005
$19,700,000
Clearsight Systems
6/30/2005
$1,000,000
Juniper Medical
6/30/2005
$3,500,000
Synovis Orthopedic and Woundcare
6/8/2005
$10,000,000
Azelon Pharmaceuticals
5/18/2005
$42,500,000
Trubion Pharmaceuticals
3/31/2005
$12,000,100
Avera Pharmaceuticals
3/31/2005
$18,000,200
Clearsight Systems
3/31/2005
$280,000
Arete Therapeutics
2/21/2005
$15,000,000
BaroSense
1/31/2005
$10,000,000
Alexza Pharmaceuticals
1/6/2005
$52,000,000
QuatRx Pharmaceuticals
12/13/2004
$31,000,000
Chimerix
11/4/2004
$11,000,000
Panomics
9/14/2004
$16,400,000
POINT Biomedical
8/19/2004
$27,100,000
Avera Pharmaceuticals
8/3/2004
$48,000,000
Trubion Pharmaceuticals
7/14/2004
$32,000,000
ZONARE Medical Systems
7/12/2004
$34,000,000
PatientKeeper
6/8/2004
$7,000,000
Amicus Therapeutics
5/12/2004
$31,000,000
Cardiac Dimensions
3/17/2004
$15,000,000
XenoPort
2/4/2004
$37,000,000
Portola Pharmaceuticals
12/8/2003
$21,000,000
CoTherix
10/14/2003
$55,000,000
Rigel Pharmaceuticals
6/27/2003
$46,000,000
QuatRx Pharmaceuticals
6/10/2003
$28,000,000
Xoft
6/2/2003
$18,000,000
Medidata Solutions
5/5/2003
$4,000,000
Panomics
1/8/2003
$8,000,000

 

Investor Contacts

Title
Name
Email & Social
General Partner
Nathan Every
  Nathan Every LinkedIn Profile  Nathan Every Twitter Account  Nathan Every News  Nathan Every on Facebook
Managing Partner
Alan Frazier
  Alan Frazier LinkedIn Profile  Alan Frazier Twitter Account  Alan Frazier News  Alan Frazier on Facebook
General Partner
Patrick Heron
  Patrick Heron LinkedIn Profile  Patrick Heron Twitter Account  Patrick Heron News  Patrick Heron on Facebook
General Partner
Benjamin Magnano
  Benjamin Magnano LinkedIn Profile  Benjamin Magnano Twitter Account  Benjamin Magnano News  Benjamin Magnano on Facebook
Partner
Brian Morfitt
  Brian Morfitt LinkedIn Profile  Brian Morfitt Twitter Account  Brian Morfitt News  Brian Morfitt on Facebook
General Partner
Nader Naini
  Nader Naini LinkedIn Profile  Nader Naini Twitter Account  Nader Naini News  Nader Naini on Facebook
General Partner
James Topper
  James Topper LinkedIn Profile  James Topper Twitter Account  James Topper News  James Topper on Facebook

 

Funds

Our database includes the following fund closing(s) for Frazier Healthcare Partners. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Frazier Life Sciences X
1/16/2020
$617,000,000
Frazier Healthcare Growth Buyout Fund IX
4/9/2018
$775,712,511
Frazier Life Sciences IX
11/1/2017
$419,000,000
Frazier Healthcare Growth Buyout Fund VIII
3/23/2016
$525,000,000
Frazier Life Sciences VIII
10/29/2015
$262,000,000
Frazier Healthcare VII
9/30/2013
$377,000,000
Frazier Healthcare VII
5/10/2013
$281,800,000
Frazier Healthcare V
6/3/2005
$474,738,307

 

Portfolio Companies

Frazier Healthcare Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Abode Healthcare
Acerta Pharma
Achaogen
Alcresta Therapeutics
Alexza Pharmaceuticals
Allena Pharmaceuticals
Alnara Pharmaceuticals
Alpha-9 Theranostics
Alpine Immune Sciences
Amicus Therapeutics
Amunix Pharmaceuticals
AnaptysBio
Apneon
Aprimo
Aptinyx
Arete Therapeutics
Ascension Orthopedics
Aspen Neuroscience
Avera Pharmaceuticals
Aveso Displays
Azelon Pharmaceuticals
Bariatric Partners
BaroSense
BARRX Medical
Bravo Health
Cadence Pharmaceuticals
Calibra Medical
Calistoga Pharmaceuticals
Calixa Therapeutics
Calypso Medical Technologies
Cardiac Dimensions
Centri Technology
Cerexa
Chimerix
Cidara Therapeutics
Cirius Therapeutics
Clearsight Systems
Clovis Oncology
Collegium Pharmaceutical
Control4
CoolSculpting
CoTherix
CVRx
Dascena
DS-IQ
EBR Systems
Elements Behavioral Health
Entasis Therapeutics
Finsphere
FlowCardia
Fovi Optics
Glaukos
Gritstone Oncology
HilleVax
Imago BioSciences
Incline Therapeutics
Inipharm
InnerPulse
Intradigm
IP Fabrics
Iterum Therapeutics
Juniper Medical
Kalidex Pharmaceuticals
Laguna Pharmaceuticals
MacuSight
Marcadia Biotech
Mavupharma
MBX Biosciences
Medidata Solutions
Medio Systems
Merganser Biotech
Metagenomi
Metastatix
Millendo Therapeutics
Mirum Pharmaceuticals
Moximed
Nuon Therapeutics
Oceana Therapeutics
Outpost Medicine
Panomics
Passage Bio
PatientKeeper
Phathom Pharmaceuticals
Pivot Medical
Pivot Trader
POINT Biomedical
Portola Pharmaceuticals
PowerVision
Precision Dermatology
Primaeva Medical
ProNAi Therapeutics
QuatRx Pharmaceuticals
Recida Therapeutics
Rempex Pharmaceuticals
Rigel Pharmaceuticals
Scout Bio
Seattle Medical Technologies
Semnur Pharmaceuticals
Seraxis
Silvergate Pharmaceuticals
SNAPin Software
Sojournix
Sonoma Biotherapeutics
StroMedix
Sudo Biosciences
SutroVax
Synovis Orthopedic and Woundcare
Tarsus Pharmaceuticals
Threshold Pharmaceuticals
Tobira Therapeutics
Trident USA Health Services
Trubion Pharmaceuticals
VentiRx Pharmaceuticals
XenoPort
Xoft
Zavante Therapeutics
ZONARE Medical Systems

 

 

 

 

Browse more venture capital investors:

Fraunhofer Venture | Frazier Life Sciences

 

Share this article

 

About Our VC Firm Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.